NLRP3 and early-onset autosomal dominant Alzheimer disease: Persistent and abnormal NLRP3 signaling is the basis of many chronic and degenerative diseases, including Stargardt disease type 1 [82], Alzheimer's disease [83], atherosclerosis [84], atrial fibrillation [85], osteoarthritis [86], and cancer [87] (Table 1).